KARAKTERISTIK KLINIS DAN FAKTOR KOMORBID PASIEN COVID-19 di RSUP DR. M. DJAMIL PADANG

Authors

  • Rosmaini Rosmaini Fakultas Kedokteran Universitas Baiturrahmah
  • Maharani Syair Fakultas Kedokteran Universitas Baiturrahmah
  • Bun Yurizali Fakultas Kedokteran Universitas Baiturrahmah
  • Suharni Suharni Fakultas Kedokteran Universitas Baiturrahmah, Padang

Keywords:

COVID-19, , clinical characteristics, comorbidity

Abstract

Coronavirus disease 2019 (COVID-19) is a potentially fatal infectious disease caused by a novel coronavirus (nCoV), Severe Acute Respiratory Syndrome Corona Virus 2 disease (SARS-CoV-2).Because the information is transmitted from person to person, the process is very quick.Passien comorbidity factor can reduce the likelihood of COVID-19 infection. The purpose of this study is to learn about the clinical characteristics and risk factors for COVID-19 at RSUP Dr. M. Djamil Padang in 2021. There is 97 people were sampled using the purposive sampling technique.  The clinical symptom characteristics of COVID-19 patients were dominated by fever (69.1%) and shortness of breath (61.9%); signs were dominated by respiratory frequency 30x/minute (76.3%); and comorbid factors were dominated by hypertension (66%) and diabetes mellitus (64.9%). The clinical characteristics of COVID-19 patients at Dr. M. Djamil Padang's clinic in 2021 are dominated by symptoms (fever and shortness of breath), signs (respiratory rate 30x/minute), and comorbid factors (hypertension and diabetes mellitus.

Downloads

Download data is not yet available.

References

Li, H. Liu, SM. Yu, XH. Tang, SL. Tang, “Coronavirus dease 2019 (COVID-19): Current S and Future Status Perspectives,” Int J Antimicrob Agent, vol. 55, no. 5, 2020, doi: 10.1016/j.ijantimicag.2020.105951.

Kementrian Kesehatan RI, Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19), 5th ed. 2020.

Pascarella, G. Stumia, A. Piliego, C. Bruno, F. Buono, RD. Costa, F. Scarlata, S. Agro, “COVID-19 Diagnosis and Management: a Comprehensive Review,” J. Intern. Medice, vol. 288, no. 2, pp. 192–206, 2020.

Cao, W. Li, T, “COVID-19: towards understanding of pathogenesis,” Cell Res., vol. 30, no. 5, pp. 367–369, 2020, doi: 10.1038/s41422-020-0327-4.

“Komite Penanganan COVID-19 dan Pemulihan Ekonomi Nasional (KPCPEN),” KPCPEN Peta Sebaran COVID-19, 2021.

“DINKES Kota Padang,” Data Pemantauan COVID-19 Kota Padang, 2021. .

Susilo, A., Rumende, C. M., Pitoya, C. W., Santoso, w. d., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G. “Coronavirus Disease 2019: Tinjauan Literatur Terkini,” J. Penyakit Dalam Indones., vol. 7, no. 1, p. 45, 2020, doi: 10.7454/jpdi.v7i1.415.

Levani., Prastya., and Mawaddatunnadila, “Coronavirus Disease 2019 (COVID-19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi,” J. Kedokt. dan Kesehat., vol. 17, no. 1, pp. 44–57, 2021.

Sugiono, Penelitian Kuantitatif Kualitatif R&D. Bandung: Alabeta Cv Bandung, 2015.

Lameshow, S. Klar, J. Lwanga, SK. Promo, D. Hosmer, DW, Besar Sampel Dalam Penelitian Kesehatan. Yokyakarta: Gajah Mada University Press, 1997.

Jin, A. Yan, B. Hua, W. Feng, D. Xu, B. Liang, L. Guo, C, “Clinical characteristics of patients diagnosed with COVID-19 in Beijing,” Biosaf. Heal., vol. 2, no. 2, pp. 104–111, 2020, doi: 10.1016/j.bsheal.2020.05.003.

Leite, VF, Rampim, DB. Jorge, VC. Lima MCC. Cezarino, LG. Rocha, CN. Esper, RB, Study PSC, “Persistent Symptoms and Disability After COVID-19 Hospitalization: Data From a Comprehensive Telerehabilitation Program,” Arch. Phys. Med. Rehabil., vol. 102, no. 7, pp. 1308–1316, 2021, doi: 10.1016/j.apmr.2021.03.001.

Azwar, MK., Setiati, S.Rizka, A.itriana, I.

Saldi, SRF. Safitri, ED, “Clinical Profile of Elderly Patients with COVID-19 Hospitalised in Indonesia’s National General Hospital,” Acta Med. Indones., vol. 52, no. 3, pp. 199–205, 2020.

Perrotta, F. Corbi, G. Mazzeo, G. Boccia, M. Aronne, L. DAgnano, V. Komici, K. Mazzarella, G. Parrella, R. Bianco, A. Aronne, L. D’Agnano, Komici, Kl. Mazzarella, G. Parrella, R. Bianco, A, “COVID-19 and the elderly: insights into pathogenesis and clinical decision-making,” Aging Clin. Exp. Res., vol. 32, no. 8, pp. 1599–1608, 2020, doi: 10.1007/s40520-020-01631-y.

Carroll JK, Arias Hernandez P, Brooks-Greisena A, Carlos, CJ. Cui, J. Ericson, B. Fagan, M. Fajt, ML, Forth, V. Fuhlbrigge, AL. Lorenzi, M. Rodrigues-Louis, J. Maher, NE. Manning, BK. Pace, WD. Shield, JB. Israel, E, “Socioeconomic Impact of COVID-19 and Willingness to be Vaccinated in African American/Black and Hispanic/Latinx adults,” J. Natl. Med. Assoc., pp. 1–11, 2022, doi: 10.1016/j.jnma.2021.12.010.

Ghadiri F, Sahraian MA, Shaygannejad V, Ashtari, F. Langroodi, HG. Baghbanian, SM. Mozhdehiapanah, H.Nasab, NM. Hosseini, S. Poursadeghfard, S. Beladimghdam, N. Razazia, N. Ayoubi, S. Rezaemanesh, N. Eskandarieh, S. Moghadasi, AN, “Characteristics of COVID-19 in patients with multiple sclerosis,” Mult. Scler. Relat. Disord., vol. 57, no. September 2021, p. 103437, 2022, doi: 10.1016/j.msard.2021.103437.

Achidsti A, Sari OK, Ratnasari DP, Ningsih, MS. Widyaningrum, AR. Maji, JS.Weiss, MUS.Muttaqin, SS, “Women’s Resilience and Vulnerability in Facing COVID-19 in DKI Jakarta and East Java,” Populasi, vol. 28, no. 2, p. 96, 2021, doi: 10.22146/jp.63388.

World Heath Organization, “Materi Komunikasi Resiko Covid-19 Untuk Fasilitas Pelayanan Kesehatan,” 2020, [Online]. Available: https://www.who.int/does/defaut-soutce/searo/indonesia/covid-19,risk-communication-for-healthcare-facility.pdf?sfvrsn=9207787a_2.

Pouw, N. de Maat J van, Veerman K, Ten Oever, J. Janssen, N. Abbink, N. Rejers, Monique, de Mast, Q. Hoefsloot, W. van Crevel, R. Slieker, K. van Apeldon, M. Blaauw, M. Dofferhoff, A.Hoogewerf, J. “Clinical Characteristics and Outcomes of 952 Hospitalized COVID-19 patients in the Netherlands: A Petrospective Cohort Study,” PLoS One, vol. 16, no. 3 March, pp. 1–15, 2021, doi: 10.1371/journal.pone.0248713.

H. Haryati, M. Isa, A. Assagaf, I. Nurrasyidah, and E. Kusumawardhani, “Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 in Ulin Regional Hospital Banjarmasin,” J. Respirasi, vol. 7, no. 1, p. 1, 2021, doi: 10.20473/jr.v7-i.1.2021.1-7.

Yang K, Sheng Y, Huang C, Jin, y. Xiong, N. Jiang, K. Lu, H. Liu, J. Yang, J. Dong, Y. Pan, D.Shu, C. Li, J. Wei, J. Huang, Y. Peng, L. Wu, M. Zhang, R. Wu, B. Li, Y. Cai, L. Li, G. Zhing, T. Wu, G, “Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Patients with Pancer and COVID-19 in Hubei, China: M multicentre, Retrospective, Cohort Study,” Lancet Oncol., vol. 21, no. 7, pp. 904–913, 2020, doi: 10.1016/S1470-2045(20)30310-7.

Lei, S. Jiang, F. Su, W. Chen, C. Chen,J,. Mei, W. Zhan, LY. Jia, Yi. Zhang, Li.. Yang K, Sheng Y, Huang C, Jin, y. Xiong, N. Jiang, K. Lu, H. Liu, J. Yang, J. Dong, Y. Pan, D.Shu, C. Li, J. Wei, J. Huang, Y. Peng, L. Wu, M. Zhang, R. Wu, B. Li, Y. Cai, L. Li, G. Zhing, T. Wu, G. “Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection,” EClinicalMedicine, vol. 21, p. 100331, 2020, doi: 10.1016/j.eclinm.2020.100331.

Liang, W., Guan, WJ. Li , CC. Li, YM. Liang, HR. Zhao, Y. Liu, XQ. Sang, L. Chen, RC. Tiang, CL. Wang, T. Wang, W. He, QH. Chen, ZS. Wong S.S. Zanin, M. Liu, J. Xu, X. Jun, H. Li, JF. Ou, LM. Cheng, B. Xiong, S. Xie, ZH. NI, ZY. Hu, Y. Liu, L. Shan, H. Le, JX, “Clinical Characteristics and Outcomes of Hospitalised Patients with COVID-19 Treated in Hubei (epicentre) and Outside Hubei (non-epicentre): A Nationwide Analysis of China,” Eur. Respir. J., vol. 55, no. 6, 2020, doi: 10.1183/13993003.00562-2020.

M. H. Gul, Z. M. Htun, and A. Inayat, “Role of fever and ambient temperature in COVID-19,” Expert Rev. Respir. Med., vol. 15, no. 2, pp. 171–173, 2021, doi: 10.1080/17476348.2020.1816172.

Hentsch, L. Cocetta, S. Allalli, G. Santana, I. Eason, R. Adam, E. Janssen J-P, “Breathlessness and COVID-19: A call for research,” Respiration, vol. 100, no. 10, pp. 1016–1026, 2021, doi: 10.1159/000517400.

, Hafiz, M. Icksan, AG. Harlivasari, AD. Aulia, R. Susant, IF. Eldinia, L. Aulia, R. Susanti, F.Eldinia, L, “Clinical, radiological features and outcome of COVID-19 patients in a secondary Hospital in Jakarta, Indonesia,” J. Infect. Dev. Ctries., vol. 14, no. 7, pp. 750–757, 2020, doi: 10.3855/jidc.12911.

U. H. Fata and L. Febriana, “Oxygen Saturation (SPO2) in Covid-19 Patients,” J. Ners dan Kebidanan (Journal Ners Midwifery), vol. 8, no. 3, pp. 290–294, 2021, doi: 10.26699/jnk.v8i3.art.p290-294.

Lohia, S. Kapu, RS. Benjaram, S. Pandey, A. Mir, T. Seyoum, B. “Metabolic syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex, and race of the patient with metabolic syndrome matter?,” J. Diabetes, vol. 13, no. 5, pp. 420–429, 2021, doi: 10.1111/1753-0407.13157.

Lohia, S. Kapu, RS. Benjaram, S. Pandey, A. Mir, T. Seyoum, B. “Risk Factors for Severity and Mortality in Adult COVID-19 Inpatients in Wuhan,” J. Allergy Clin. Immunol., vol. 146, no. 1, pp. 110–118, 2020, doi: 10.1016/j.jaci.2020.04.006.

Karyono, DR.. Wicaksana, AL. “Current Prevalence, Characteristics, and Comorbidities of Patients with COVID-19 in Indonesia,” J. Community Empower. Heal., vol. 3, no. 2, p. 77, 2020, doi: 10.22146/jcoemph.57325.

Lim, S. Bae, JH. Kwon, HS. Nauck, MA, “COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management,” Nat. Rev. Endocrinol., vol. 17, no. 1, pp. 11–30, 2021, doi: 10.1038/s41574-020-00435-4.

Downloads

Published

2023-01-05

How to Cite

Rosmaini, R., Syair, M., Yurizali, B. ., & Suharni, S. (2023). KARAKTERISTIK KLINIS DAN FAKTOR KOMORBID PASIEN COVID-19 di RSUP DR. M. DJAMIL PADANG. Nusantara Hasana Journal, 2(8), 252–258. Retrieved from https://nusantarahasanajournal.com/index.php/nhj/article/view/676

Most read articles by the same author(s)